NCT03044847Enrolling by invitation
The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China
The Cohort Study for Chronic Obstructive Pulmonary Diseases (COPD) in China---- Observation of the Disease Outcome and Identification of Prognostic Biomarkers for the Disease Outcome
Source: ClinicalTrials.gov · Last updated 29 Jul 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to establish the large COPD cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices and to monitor and improve clinical outcomes in this disease.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 3800 (estimated)
- First submitted
- 25 Jan 2017
- Start date
- 1 Jul 2016
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Beijing Chao Yang Hospital
- Diseases
- COPD
- NCT number
- NCT03044847
What you commit to
- Study type: Observational
- Planned participants: 3800
- From 1 Jul 2016 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- thoracic or abdominal surgery in the last 3 months
- eye surgery in the last three months
Other illness
- Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc
- The usual criteria of serious uncontrolled diseases
- myocardial infarction in the last 3 months
- admission to hospital for any cardiac condition in the last month
- heart rate over 120 beats per minute
- antibacterial chemotherapy for tuberculosis
Other
- Acute exacerbation in the past 3 months
- retinal detachment
- pregnant or breast feeding
Who the study is looking for
- Aged 40-75 years
- COPD group: baseline post-bronchodilator FEV1/FVC \< 0.7
- GOLD 0 group: individuals with chronic respiratory symptoms and/or high risk factors
- Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years
Age in the registry: 40 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.